Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Allarity Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Allarity Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.71M. For fiscal 2025 it was -$14.82M. The highest annual figure on record is -$7.25M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.82M | – |
| FY2024 | Dec 31, 2024 | -$17.35M | – |
| FY2023 | Dec 31, 2023 | -$12.75M | – |
| FY2022 | Dec 31, 2022 | -$16.82M | – |
| FY2021 | Dec 31, 2021 | -$14.89M | – |
| FY2020 | Dec 31, 2020 | -$7.25M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.56M | – |
| Q1 FY2026 | Mar 31, 2026 | -$4.49M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.24M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.41M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.48M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.69M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.21M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$7.30M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.40M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.41M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.21M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.32M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.73M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.57M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.44M | – |
See a number that looks wrong?